ImmuCell Corporation Proceeds from Issuance of Private Placement
ImmuCell Corporation (ICCC) reported Proceeds from Issuance of Private Placement of $1.03 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2019-03-22
- ImmuCell Corporation proceeds from issuance of private placement for the quarter ending 2017-12-31 was -$3.00K.
- ImmuCell Corporation proceeds from issuance of private placement for fiscal 2017 was $1.03M, a 67.28% decline from fiscal 2016.
- ImmuCell Corporation proceeds from issuance of private placement for fiscal 2016 was $3.16M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|
| 2017-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $1.03M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $1.04M 10-Q · filed 2018-11-13 | ||
| 2016-12-31 | $3.16M 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |